Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Fri, 25.04.2025
Xlife Sciences AG
Zurich, 25th of April 2025: Xlife Sciences AG ("Xlife Sciences", SIX: XLS) today published its 2024 Annual Report. The past fiscal year was marked by strategically significant partnerships and technological breakthroughs within its portfolio companies.
«2024 was a successful year for Xlife Sciences in terms of technological progress within our port [ … ]
Fri, 25.04.2025
Swiss Life Holding AG
Zurich, 25 April 2025
Ad hoc announcement pursuant to Art. 53 LR
Swiss Life is publishing its financial condition report today. This complements the 2024 Annual Report, which has already been published, and provides information on business operations, governance and risk management as well as details of Swiss Life’s solvency. The report is availab [ … ]
Fri, 25.04.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
April 25, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at March 31, 2025, which covers the results of its business activities for the first three months of 2025.
Based on the consolidated accounts of BB Biotech AG, net loss for [ … ]
Fri, 25.04.2025
Holcim Group Services Ltd
Stable net sales of CHF 5,544 million
Over-proportional recurring EBIT growth of +1.7% in local currency
M&A momentum continues with five value-accretive acquisitions
Confirming Amrize spin-off on track, listing expected in June 2025
Full-year guidance 2025 confirmed
Miljan Gutovic, CEO: “I thank all my Holcim colleagues for their dedication [ … ]
Thu, 24.04.2025
Merck KGaA
Darmstadt, April 24, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms late-stage discussions with SpringWorks Therapeutics, Inc. on a potential acquisition. The parties are in discussion on the basis of a price of around USD 47 per share. Merck notes that no final decision has been taken and no legally binding agreement has been ent [ … ]
Thu, 24.04.2025
Brockhaus Technologies AG
Brockhaus Technologies AG: Postponement of the Annual General Meeting
Frankfurt am Main, April 24, 2025
The Management Board of Brockhaus Technologies AG (“Brockhaus Technologies” or the “Company”, ISIN: DE000A2GSU42) has today decided to postpone the Annual General Meeting originally scheduled for June 25, 2025. The background to this is the on [ … ]
Thu, 24.04.2025
The NAGA Group AG
Ad hoc announcement pursuant to Art. 17 Market Abuse Regulation
- The NAGA Group acquires Trade.com UK -
Hamburg, 24 April 2025 – The financial technology company The NAGA Group AG, through its subsidiary Key Way Group Ltd., Gibraltar, has entered into a purchase agreement to acquire all shares in Trade Capital UK (TCUK) Ltd, a financial [ … ]
Thu, 24.04.2025
Forbo Holding AG
MEDIA RELEASE
AD HOC ANNOUNCEMENT PURSUANT TO ARTICLE 53 OF THE SIX EXCHANGE REGULATION LISTING RULES
Baar, April 24, 2025
On February 20, 2025, the Forbo Group announced that CEO Jens Fankhänel was temporarily taking a step back from the operational business for health reasons. Since then, CFO Andreas Jaeger has headed the Forbo Group as CEO ad i [ … ]
Thu, 24.04.2025
Uniper SE
Uniper SE: Uniper expects a significant decline in earnings for the first quarter of financial year 2025. Earnings outlook for financial year 2025 remains unchanged.
Uniper expects earnings for the first three months of financial year 2025 to be significantly below the previous year's figures. Based on preliminary and unaudited figures, Uniper exp [ … ]
Thu, 24.04.2025
Enapter AG
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014 Enapter AG adjusts preliminary EBITDA for financial year 2024
On February 27, 2025, Enapter AG (ISIN: DE000A255G02) announced an EBITDA expectation based on preliminary and unaudited figures for 2024 of approx. EUR -8.6 million was published.
According to the pr [ … ]